BACKGROUND: Colorectal cancer (CRC) screening rates are suboptimal. The most important barriers identified by patients are poorly understood. A comprehensive assessment of barriers to all recommended modalities is needed. METHODS: In 2007, a questionnaire was mailed to 6100 patients, aged 50-75 years, from 12 family medicine practices in the Virginia Ambulatory Care Outcomes Research Network. People aged 65-75 years and African Americans were oversampled. Patients were asked to rate 19-21 barriers to each of four recommended tests. In 2008, responses were coded on a 5-point scale; higher scores reflected stronger barrier endorsement. RESULTS: The response rate was 55% (n=3357). Approximately 40% of respondents were aged >/=65 years, 30% were African-American, and 73% were adherent to screening. A clinician's failure to suggest screening and not knowing testing was necessary received the highest mean scores as barriers. Financial concerns and misconceptions were also cited. Barrier scores differed depending on whether respondents were never screened, overdue for screening, or adherent to guidelines. The top five barriers for each modality included test-specific barriers (e.g., handling stool, bowel preparation), which often outranked generic barriers to screening. Not knowing testing was necessary was a top barrier for all tests but colonoscopy. CONCLUSIONS: Although physician advice and awareness of the need for screening are important, barriers to screening are not homogenous across tests, and test-specific barriers warrant consideration in designing strategies to improve screening rates. Barrier scores differ by screening status, highlighting the need to address prior screening experience. Evidence that patients are more familiar with colonoscopy than with other modalities suggests an opportunity to improve screening rates by educating patients about alternative tests. 2010 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
BACKGROUND:Colorectal cancer (CRC) screening rates are suboptimal. The most important barriers identified by patients are poorly understood. A comprehensive assessment of barriers to all recommended modalities is needed. METHODS: In 2007, a questionnaire was mailed to 6100 patients, aged 50-75 years, from 12 family medicine practices in the Virginia Ambulatory Care Outcomes Research Network. People aged 65-75 years and African Americans were oversampled. Patients were asked to rate 19-21 barriers to each of four recommended tests. In 2008, responses were coded on a 5-point scale; higher scores reflected stronger barrier endorsement. RESULTS: The response rate was 55% (n=3357). Approximately 40% of respondents were aged >/=65 years, 30% were African-American, and 73% were adherent to screening. A clinician's failure to suggest screening and not knowing testing was necessary received the highest mean scores as barriers. Financial concerns and misconceptions were also cited. Barrier scores differed depending on whether respondents were never screened, overdue for screening, or adherent to guidelines. The top five barriers for each modality included test-specific barriers (e.g., handling stool, bowel preparation), which often outranked generic barriers to screening. Not knowing testing was necessary was a top barrier for all tests but colonoscopy. CONCLUSIONS: Although physician advice and awareness of the need for screening are important, barriers to screening are not homogenous across tests, and test-specific barriers warrant consideration in designing strategies to improve screening rates. Barrier scores differ by screening status, highlighting the need to address prior screening experience. Evidence that patients are more familiar with colonoscopy than with other modalities suggests an opportunity to improve screening rates by educating patients about alternative tests. 2010 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
Authors: Alexander R Green; Angelleen Peters-Lewis; Sanja Percac-Lima; Joseph R Betancourt; James M Richter; Maria-Pamela R Janairo; Gloria B Gamba; Steven J Atlas Journal: J Gen Intern Med Date: 2008-03-19 Impact factor: 5.128
Authors: Jean A Shapiro; Laura C Seeff; Trevor D Thompson; Marion R Nadel; Carrie N Klabunde; Sally W Vernon Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-07 Impact factor: 4.254
Authors: Maria E Fernandez; Rosario Wippold; Isabel Torres-Vigil; Theresa Byrd; Diamond Freeberg; Yadvindera Bains; Jessica Guajardo; Steven S Coughlin; Sally W Vernon Journal: Cancer Causes Control Date: 2007-11-24 Impact factor: 2.506
Authors: Gwen L Alexander; George W Divine; Mick P Couper; Jennifer B McClure; Melanie A Stopponi; Kristine K Fortman; Dennis D Tolsma; Victor J Strecher; Christine Cole Johnson Journal: Am J Prev Med Date: 2008-05 Impact factor: 5.043
Authors: Ann G Zauber; Iris Lansdorp-Vogelaar; Amy B Knudsen; Janneke Wilschut; Marjolein van Ballegooijen; Karen M Kuntz Journal: Ann Intern Med Date: 2008-10-06 Impact factor: 25.391
Authors: Ann Scheck McAlearney; Katherine W Reeves; Stephanie L Dickinson; Kimberly M Kelly; Cathy Tatum; Mira L Katz; Electra D Paskett Journal: Cancer Date: 2008-01-15 Impact factor: 6.860
Authors: Cam Escoffery; Maria E Fernandez; Sally W Vernon; Shuting Liang; Annette E Maxwell; Jennifer D Allen; Andrea Dwyer; Peggy A Hannon; Marlana Kohn; Amy DeGroff Journal: J Public Health Manag Pract Date: 2015 Sep-Oct
Authors: Elisabeth F P Peterse; Reinier G S Meester; Andrea Gini; Chyke A Doubeni; Daniel S Anderson; Franklin G Berger; Ann G Zauber; Iris Lansdorp-Vogelaar Journal: Health Aff (Millwood) Date: 2017-12 Impact factor: 6.301
Authors: Joel G Fletcher; Alvin C Silva; Jeff L Fidler; Joseph G Cernigliaro; Armando Manduca; Paul J Limburg; Lynn A Wilson; Trudy A Engelby; Garrett Spencer; W Scott Harmsen; Jay Mandrekar; C Daniel Johnson Journal: AJR Am J Roentgenol Date: 2013-10 Impact factor: 3.959
Authors: Caitlin C Murphy; Amy McQueen; L Kay Bartholomew; Deborah J Del Junco; Sharon P Coan; Sally W Vernon Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-09-20 Impact factor: 4.254
Authors: Lindsay M Sabik; Kirsten Y Eom; Bassam Dahman; Jie Li; Nengliang Yao; G J van Londen; Cathy J Bradley Journal: Med Care Date: 2020-02 Impact factor: 2.983
Authors: Ronald E Myers; Randa Sifri; Constantine Daskalakis; Melissa DiCarlo; Praveen Ramakrishnan Geethakumari; James Cocroft; Christopher Minnick; Nancy Brisbon; Sally W Vernon Journal: J Natl Cancer Inst Date: 2014-12-06 Impact factor: 13.506
Authors: Alex H Krist; Camille J Hochheimer; Roy T Sabo; Jon Puro; Eric Peele; Paulette Lail-Kashiri; Sally W Vernon Journal: J Am Board Fam Med Date: 2020 Sep-Oct Impact factor: 2.657